Introduction

Opioid use disorder (OUD) continues to pose a serious public health challenge in San Diego and across Southern California. In recent years, however, the rapid spread of illicitly manufactured fentanyl has dramatically altered the local drug landscape. As a result, overdose risk has sharply increased throughout San Diego County, affecting individuals, families, and communities across the region.

At the national level, the Centers for Disease Control and Prevention reports that synthetic opioids primarily fentanyl now account for the majority of opioid overdose deaths in the United States. Consequently, San Diego County reflects these broader national trends. In response, local public health officials actively monitor fentanyl-related overdoses, emergency department visits, and toxicology findings. Through ongoing surveillance and data analysis, they work to better understand evolving patterns and implement targeted prevention strategies.

Opioid use disorder is a chronic but treatable medical condition that changes brain chemistry, influences behavior, and creates physical dependence. When clinicians diagnose OUD early and begin evidence-based treatment promptly, they lower overdose risk and improve long-term recovery outcomes for people living in San Diego and nearby communities such as Chula Vista, El Cajon, Oceanside, and Escondido.

Local San Diego Statistics

Recent data from the San Diego County Health and Human Services Agency shows that fentanyl continues to drive a significant portion of opioid-related deaths in the region. In recent reporting years, fentanyl has been involved in the majority of opioid overdose deaths in San Diego County, reflecting a sharp increase compared to trends seen prior to 2019.

In addition, county public health surveillance data indicates that emergency department visits related to opioid overdose remain elevated, particularly among young adults and individuals with prior substance use history. These local patterns mirror statewide findings reported by the California Department of Public Health, which identify synthetic opioids as a leading cause of accidental drug-related death across California.

Key Causes and Risk Factors in San Diego

Opioid use disorder develops through a combination of biological, psychological, and environmental factors. In San Diego County, several recognized risk factors contribute to vulnerability.

Exposure to Prescription or Illicit Opioids

Initial exposure may occur through:

• Prescription pain treatment following injury or surgery
• Non-medical use of prescription opioids
• Illicit opioid use, including heroin

Repeated opioid exposure activates mu-opioid receptors in the brain, increasing dopamine release and reinforcing continued use. Over time, neuro adaptation leads to tolerance and dependence.

Co-Occurring Mental Health Conditions

Individuals in San Diego with untreated depression, anxiety, trauma-related disorders, or other psychiatric conditions face increased risk of opioid misuse. The National Institute on Drug Abuse notes that co-occurring mental health disorders significantly raise the likelihood of developing substance use disorders.

Chronic Pain

Patients managing chronic pain in San Diego, California may be exposed to long-term opioid therapy. Without careful monitoring and multimodal pain strategies, dependence can develop.

Environmental and Social Stressors

Housing instability, unemployment, and limited healthcare access in parts of San Diego County increase the likelihood of untreated substance use disorders.

OUD is not caused by a lack of willpower. It is a medical condition shaped by multiple interacting risk factors.

Why Fentanyl-Related Overdose Is Increasing in San Diego

The rising overdose risk in San Diego, California is closely linked to illicit fentanyl.

What Makes Fentanyl Dangerous

Fentanyl is a synthetic opioid that is significantly more potent than morphine. While pharmaceutical fentanyl is used safely in controlled medical environments, illicitly manufactured fentanyl differs in key ways:

• It is often produced without consistent dosing standards
• It is mixed into heroin, methamphetamine, and cocaine
• It is pressed into counterfeit pills resembling prescription medications
• Users frequently do not know fentanyl is present

Even small amounts can cause rapid respiratory depression.

Polysubstance Overdose in San Diego

Public health surveillance in San Diego County has documented increasing cases of polysubstance overdose. Combining opioids with:

• Alcohol
• Benzodiazepines
• Stimulants

Greatly increases the risk of fatal respiratory suppression.

Unpredictable Drug Supply

The instability of the illicit drug market in Southern California makes potency unpredictable. Individuals may consume fentanyl unknowingly, leading to sudden overdose events.

Who Is Most at Risk in San Diego County

Opioid use disorder affects individuals across all demographics in San Diego, California, but certain populations face higher risk.

Individuals With Prior Opioid Use Disorder

People with established OUD who are not engaged in treatment remain at high risk for relapse and overdose.

Individuals With Reduced Tolerance

After periods of abstinence such as incarceration, detoxification, or hospitalization tolerance decreases. Resuming previous opioid doses significantly increases overdose risk.

Young Adults in San Diego

Counterfeit pills containing fentanyl have contributed to overdose risk among young adults in San Diego County who may not identify as having opioid use disorder.

Individuals Experiencing Housing Instability

Housing insecurity in parts of San Diego is associated with increased exposure to high-risk drug environments and reduced access to consistent care.

Individuals With Co-Occurring Mental Health Disorders

Untreated psychiatric illness remains a major contributor to relapse and overdose risk.

Prevention and Treatment Options in San Diego, California

Opioid use disorder is treatable. Evidence-based interventions reduce mortality and improve recovery outcomes.

Naloxone Distribution

Naloxone is an opioid antagonist that reverses overdose by restoring breathing. The Centers for Disease Control and Prevention recommends widespread community access to naloxone, particularly in high-risk areas such as urban regions of San Diego County.

Medication-Assisted Treatment (MAT)

The Substance Abuse and Mental Health Services Administration identifies medication-assisted treatment as the gold standard for opioid use disorder.

Approved medications include:

Buprenorphine (Suboxone)

Buprenorphine is a partial opioid agonist that:

• Reduces cravings
• Minimizes withdrawal symptoms
• Has a ceiling effect that lowers respiratory depression risk
• Reduces overdose mortality

When combined with naloxone (Suboxone), misuse potential is further reduced.

Methadone

Methadone is a full opioid agonist administered through regulated opioid treatment programs.

Naltrexone

Naltrexone is an opioid antagonist that blocks opioid receptor activity.

Extensive NIH-supported research demonstrates that patients receiving MAT are significantly less likely to die from overdose compared to those not receiving medication.

Behavioral and Psychosocial Support

In San Diego, California, comprehensive addiction treatment may include:

• Individual counseling
• Peer recovery support
• Case management services
• Mental health treatment

Combining medication with behavioral support improves long-term stability.

How Physician-Led Telehealth Treatment Helps in San Diego

Telehealth has expanded access to evidence-based treatment in San Diego County, particularly for individuals facing transportation or scheduling barriers.

Physician-led telehealth programs provide:

• Comprehensive medical evaluation
• Diagnosis using DSM-5 criteria
• Safe induction onto buprenorphine when clinically appropriate
• Ongoing dose monitoring and stabilization
• Management of co-occurring medical conditions
• Compliance with California and federal prescribing regulations

When structured properly, telehealth MAT maintains the same clinical standards as in-person care.

How DevotedDOC Provides Care in California

DevotedDOC offers physician-led telehealth treatment for opioid use disorder throughout California, including patients in San Diego and surrounding communities.

Physician-Led Suboxone Treatment

Patients receive evaluation by licensed physicians experienced in addiction medicine. Care includes:

• Diagnostic assessment for opioid use disorder
• Determination of clinical appropriateness for Suboxone
• Structured medication initiation
• Ongoing stabilization and monitoring

Telehealth Access in San Diego

Secure, HIPAA-compliant virtual visits allow patients in San Diego, California to access treatment privately from home.

Evidence-Based Care

Treatment protocols align with guidance from:

• Centers for Disease Control and Prevention
• Substance Abuse and Mental Health Services Administration
• National Institute on Drug Abuse

Clinicians individualize each clinical decision to ensure it is medically appropriate.

Confidential Treatment

Secure telehealth systems that comply with federal healthcare privacy regulations protect patient confidentiality. Care is discreet and professional.

The focus is long-term stabilization not short-term prescribing.

Conclusion

Opioid use disorder continues to be a significant medical concern in San Diego, California. In particular, the widespread presence of illicit fentanyl has further intensified overdose risk across San Diego County and surrounding communities. As a result, individuals and families throughout the region face increased exposure to unpredictable and potentially life-threatening substances.

For this reason, evidence-based treatment plays a critical role in reducing harm. Medication-assisted treatment significantly lowers mortality rates among individuals with opioid use disorder. At the same time, physician-led telehealth programs help expand access to care, especially for those facing transportation or scheduling barriers, while still maintaining strict regulatory compliance and appropriate clinical oversight.

Therefore, if you or someone in San Diego is experiencing opioid misuse or withdrawal symptoms, seeking early medical evaluation is essential. Prompt assessment and structured treatment can substantially reduce overdose risk and, over time, improve long-term recovery outcomes.

Opioid use disorder is a medical condition. Effective treatment is available in San Diego, California.

Confidential, Physician-Led Opioid Treatment Available in San Diego

If you or someone in San Diego County is struggling with opioid misuse, fentanyl exposure, or withdrawal symptoms, seeking early medical care is critically important. With timely evaluation and appropriate treatment, overdose risk can be significantly reduced, and long-term stability becomes more achievable.

To help address this urgent need, DevotedDOc provides:

• Physician-led Suboxone treatment in San Diego
• Same-week telehealth appointments for faster access to care
• Secure, HIPAA-compliant virtual visits that protect your privacy
• Care aligned with CDC, SAMHSA, and California prescribing standards to ensure medical appropriateness and regulatory compliance

In addition, we serve patients throughout San Diego County and nearby communities, including:
San Diego • Chula Vista • El Cajon • Oceanside • Escondido • National City • La Mesa • Carlsbad

Wherever you are in the region, structured, physician-led treatment remains accessible and confidential.

Take the Next Step Toward Stabilization

👉 Schedule a Same-Week Telehealth Appointment
👉 Call (213) 786-3063 for Confidential Assistance
👉 Learn More About Suboxone Treatment in San Diego

Evidence-based treatment can reduce overdose risk and support long-term recovery.

Frequently Asked Questions

Medically Reviewed By

Dr. Keith Baker, MD

Addiction Medicine | Medical Toxicology | Emergency Medicine

Dr. Keith Baker, MD is a board-certified emergency physician with additional board certifications in medical toxicology and addiction medicine. He advises DevotedDOc’s executive leadership team and helps guide the clinical direction of the organization. His focus includes protocol design, risk management, and compliance-forward standards that support safe, accountable care at scale. Dr. Baker is committed to delivering evidence-based addiction treatment through telehealth. He brings frontline emergency experience and toxicology-informed risk assessment to every clinical decision. As a result, treatment protocols remain practical, consistent, and centered on patient safety. He works closely with CEO Dr. Matthew Berrios to strengthen prescribing safeguards, improve documentation standards, and refine clinical workflows. In addition, he helps develop structured follow-up systems that promote long-term stability. This approach ensures patients receive high-integrity care, clear treatment plans, and measurable outcomes.

References

1. Centers for Disease Control and Prevention. Drug Overdose Deaths in the U.S. – Synthetic Opioids (Fentanyl). U.S. Department of Health and Human Services.
2. National Institute on Drug Abuse. Co-Occurring Substance Use and Mental Health Disorders Research Reports.
3. Substance Abuse and Mental Health Services Administration. Medication-Assisted Treatment (MAT) for Opioid Use Disorder.
4. National Institutes of Health. Evidence on Medications for Opioid Use Disorder and Overdose Mortality Reduction.
5. San Diego County Health and Human Services Agency. Behavioral Health Services and Overdose Surveillance Reports.
6. California Department of Public Health. California Opioid and Fentanyl Overdose Data Dashboard.
7. Centers for Disease Control and Prevention. Naloxone Access and Community Distribution Guidance.